Basic Information

Terpenoid ID TKC032619
Chirality TKC149924
Cell line 0
Protein target 34
DiseaseNCIT 0
ORDO 0
ICD 112

Active subnetwork


Terpenoid-cell-disease Activity Association

ID Cell Line Synonyms Value Unit Type NCIt ORDO
TKC032619 HepG2 12589.0 nM Potency C3728 Orphanet_449
TKC032619 UACC-62 UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 16800.0 nM GI50 C3224
TKC032619 MCF7 16400.0 nM GI50 C4194
TKC032619 SF-268 SF-268; SF.268; SF 268 25100.0 nM GI50 C60781 Orphanet_94
TKC032619 SF-295 SF-295; SF.295; SF 295 28900.0 nM GI50 C3058 Orphanet_360
TKC032619 SF-539 SF-539; SF-539 BT; SF.539; SF 539 18900.0 nM GI50 C3796 Orphanet_251576
TKC032619 SNB-19 SNB.19; SNB19; Surgical Neurology Branch-19 70900.0 nM GI50 C60781 Orphanet_94
TKC032619 SNB-75 SNB.75; SNB75; Surgical Neurology Branch-75 48400.0 nM GI50 C3058 Orphanet_360
TKC032619 U-251 U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) 41500.0 nM GI50 C60781 Orphanet_94
TKC032619 Malme-3M MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer 13800.0 nM GI50 C3224
TKC032619 LOX IMVI LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX 8240.0 nM GI50 C3802
TKC032619 SK-MEL-2 SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 16200.0 nM GI50 C3224
TKC032619 SK-MEL-28 SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 21000.0 nM GI50 C3510
TKC032619 SK-MEL-5 SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel 17400.0 nM GI50 C3510
TKC032619 UACC-257 UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 14400.0 nM GI50 C3224
TKC032619 SW-620 SW-620; SW 620; SW.620 14500.0 nM GI50 C4349
TKC032619 KM12 KM-12; KM.12 16200.0 nM GI50 C4910
TKC032619 HCT-15 HCT-15; HCT.15; HCT15 10200.0 nM GI50 C4349
TKC032619 HCT-116 HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 10800.0 nM GI50 C4910
TKC032619 HCC 2998 HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 24100.0 nM GI50 C4349
TKC032619 COLO 205 Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 14500.0 nM GI50 C4349
TKC032619 NCI-H522 NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 5470.0 nM GI50 C3512
TKC032619 NCI-H460 NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 18800.0 nM GI50 C4450
TKC032619 NCI-H322M NCI.H322M; H322M; H-322M; H-322m 21700.0 nM GI50 C2923
TKC032619 NCI-H23 NCI.H23; NCI H23; H-23; H23; NCIH23 20200.0 nM GI50 C3512
TKC032619 NCI-H226 NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 20500.0 nM GI50 C45662 Orphanet_50251
TKC032619 HOP-92 HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 13500.0 nM GI50 C2926
TKC032619 HOP-62 HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 49000.0 nM GI50 C3512
TKC032619 EKVX 17300.0 nM GI50 C3512
TKC032619 A549 29700.0 nM LC50 C3512
TKC032619 RPMI-8226 RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson 8200.0 nM GI50 C3242 Orphanet_29073
TKC032619 CCRF-CEM CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C 9160.0 nM GI50 C7953 Orphanet_99861
TKC032619 HL-60(TB) HL-60 (TB); HL-60-TB; HL-60TB; HL-60 TB 5710.0 nM GI50 C9154 Orphanet_519
TKC032619 K562 K562; K.562; K 562; KO; GM05372; GM05372E 22600.0 nM GI50 C9110 Orphanet_521
TKC032619 MOLT-4 Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D 14300.0 nM GI50 C9142 Orphanet_99861
TKC032619 IGROV-1 Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P 21100.0 nM GI50 C7979 Orphanet_454723
TKC032619 OVCAR-3 Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 17400.0 nM GI50 C105555
TKC032619 OVCAR-4 OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 21500.0 nM GI50 C105555
TKC032619 OVCAR-5 OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 34100.0 nM GI50 C105555
TKC032619 OVCAR-8 OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 17100.0 nM GI50 C105555
TKC032619 NCI/ADR-RES NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR 15000.0 nM GI50 C105555
TKC032619 SK-OV-3 SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 54700.0 nM GI50 C7978
TKC032619 A498 A498 7040.0 nM GI50 C9385 Orphanet_217071
TKC032619 CAKI-1 CAL 1; Centre Antoine Lacassagne-1 9350.0 nM GI50 C3224
TKC032619 RXF 393 RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL 12200.0 nM GI50 C9385 Orphanet_217071
TKC032619 SN12C SN-12C 22800.0 nM GI50 C9385 Orphanet_217071
TKC032619 UO-31 UO.31; UO31; U031 41900.0 nM GI50 C9385 Orphanet_217071
TKC032619 PC-3 PC3; PC.3 20500.0 nM LC50 C4863
TKC032619 MDA-MB-231 MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 18300.0 nM LC50 C5214
TKC032619 MOLM-13 MOLM13; Molm13; Molm 13 10000.0 nM IC50 C9154 Orphanet_519
TKC032619 EOL1 EOL-1; EOL1; EoL-1-cell; EoL-1 cell; AML-EOL-1 7500.0 nM IC50 C4563 Orphanet_168940
TKC032619 JeKo-1 Jeko-1; JEKO-1; JeKo 1; Jeko1; JEKO1; JEKO 48.0 % Activity C4337 Orphanet_52416
TKC032619 Jurkat JURKAT; JM; JM-Jurkat; Jurkat-FHCRC; Jurkat FHCRC; FHCRC-11; FHCRC subclone 11; FCCH1024 70.0 % Activity C7953 Orphanet_99861
TKC032619 HeLa HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri 35.0 % Activity C27677
TKC032619 SJSA-1 SJSA1; SJSA; OsA-CL; OSA-CL; OsACL; OSACL; Os-A; OSA; OsA 100.0 % Activity C9145 Orphanet_668
TKC032619 SK-N-MC SKNMC; SK-NM-C; SK-NMC 30.0 % Activity C7542 Orphanet_370348
TKC032619 Bel7402/5-FU Bel7402/5-FU; BEL-7402/FU; Bel/5Fu 12980.0 nM IC50 C27677
TKC032619 Bel-7402 Bel-7402; BEL 7402; Bel 7402; BEL7402; Bel7402 8620.0 nM IC50 C27677
TKC032619 MEC1 Mouse Epicardial Cells 1 6200.0 nM EC50
TKC032619 HL-60 HL 60; HL.60 HL60; Human Leukemia-60 4688.0 nM GI50 C9154 Orphanet_519
TKC032619 HEK293 1413.0 nM Potency
TKC032619 SH-SY5Y SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental 35481.0 nM Potency C3270 Orphanet_635
TKC032619 SN12C SN-12C 22856.0 nM GI50 C9385 Orphanet_217071
TKC032619 NCI-H23 NCI.H23; NCI H23; H-23; H23; NCIH23 20230.0 nM GI50 C3512
TKC032619 UO-31 UO.31; UO31; U031 41976.0 nM GI50 C9385 Orphanet_217071
TKC032619 HOP-92 HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 13583.0 nM GI50 C2926
TKC032619 SF-539 SF-539; SF-539 BT; SF.539; SF 539 18967.0 nM GI50 C3796 Orphanet_251576
TKC032619 SK-MEL-5 SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel 17458.0 nM GI50 C3510
TKC032619 Malme-3M MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer 13366.0 nM GI50 C3224
TKC032619 A498 A498 7047.0 nM GI50 C9385 Orphanet_217071
TKC032619 K562 K562; K.562; K 562; KO; GM05372; GM05372E 21827.0 nM GI50 C9110 Orphanet_521
TKC032619 OVCAR-3 Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 18408.0 nM GI50 C105555
TKC032619 MOLT-4 Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D 14158.0 nM GI50 C9142 Orphanet_99861
TKC032619 NCI/ADR-RES NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR 15031.0 nM GI50 C105555
TKC032619 HOP-62 HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 49091.0 nM GI50 C3512
TKC032619 U-251 U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) 41591.0 nM GI50 C60781 Orphanet_94
TKC032619 OVCAR-5 OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 34198.0 nM GI50 C105555
TKC032619 OVCAR-8 OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 16749.0 nM GI50 C105555
TKC032619 SNB-19 SNB.19; SNB19; Surgical Neurology Branch-19 63680.0 nM GI50 C60781 Orphanet_94
TKC032619 DMS-273 DMS-273; DMS273; Darmouth Medical School 273 24604.0 nM GI50 C4917 Orphanet_70573
TKC032619 SW-620 SW-620; SW 620; SW.620 14757.0 nM GI50 C4349
TKC032619 M19-MEL M-19; M19 14322.0 nM GI50 C3802
TKC032619 NCI-H522 NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 5470.0 nM GI50 C3512
TKC032619 KM12 KM-12; KM.12 16788.0 nM GI50 C4910
TKC032619 XF498 XF-498; XF498 16866.0 nM GI50 C3058 Orphanet_360
TKC032619 NCI-H322M NCI.H322M; H322M; H-322M; H-322m 19498.0 nM GI50 C2923
TKC032619 RPMI-8226 RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson 8710.0 nM GI50 C3242 Orphanet_29073
TKC032619 OVCAR-4 OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 21577.0 nM GI50 C105555
TKC032619 LOX IMVI LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX 8241.0 nM GI50 C3802
TKC032619 P388 P-388 6592.0 nM GI50 C21602
TKC032619 SK-MEL-2 SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 16218.0 nM GI50 C3224
TKC032619 A549 94624.0 nM GI50 C3512
TKC032619 KM-20L2 KM-20L2; KM 20L2; KM 2012 24774.0 nM GI50 C4349
TKC032619 HCC 2998 HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 24155.0 nM GI50 C4349
TKC032619 SNB-75 SNB.75; SNB75; Surgical Neurology Branch-75 48417.0 nM GI50 C3058 Orphanet_360
TKC032619 HCT-15 HCT-15; HCT.15; HCT15 14655.0 nM GI50 C4349
TKC032619 HCT-116 HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 10328.0 nM GI50 C4910
TKC032619 SF-268 SF-268; SF.268; SF 268 23659.0 nM GI50 C60781 Orphanet_94
TKC032619 MCF7 16406.0 nM GI50 C4194
TKC032619 EKVX 17378.0 nM GI50 C3512
TKC032619 DMS-114 DMS-114; DMS114; Darmouth Medical School 114 45920.0 nM GI50 C4917 Orphanet_70573
TKC032619 SK-OV-3 SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 54702.0 nM GI50 C7978
TKC032619 NCI-H460 NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 18836.0 nM GI50 C4450
TKC032619 UACC-62 UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 16827.0 nM GI50 C3224
TKC032619 CAKI-1 CAL 1; Centre Antoine Lacassagne-1 9311.0 nM GI50 C3224
TKC032619 P388/ADR 4842.0 nM GI50 C21602
TKC032619 IGROV-1 Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P 21135.0 nM GI50 C7979 Orphanet_454723
TKC032619 SF-295 SF-295; SF.295; SF 295 24774.0 nM GI50 C3058 Orphanet_360
TKC032619 UACC-257 UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 14859.0 nM GI50 C3224
TKC032619 SNB-78 SNB78; Surgical Neurology Branch-78 18155.0 nM GI50 C3058 Orphanet_360
TKC032619 CCRF-CEM CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C 8375.0 nM GI50 C7953 Orphanet_99861
TKC032619 DLD-1 DLD 1; DLD1; CoCL3 12474.0 nM GI50 C4349
TKC032619 NCI-H226 NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 20512.0 nM GI50 C45662 Orphanet_50251
TKC032619 SK-MEL-28 SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 21086.0 nM GI50 C3510
TKC032619 HT-29 HT 29; HT29 23550.0 nM GI50 C4349
TKC032619 RXF 393 RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL 12190.0 nM GI50 C9385 Orphanet_217071
TKC032619 COLO 205 Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 14454.0 nM GI50 C4349
TKC032619 HOP-18 HOP 18; Hop 18; HOP18; Hop18; Hopkins-18 14894.0 nM GI50 C4450
TKC032619 SN12K1 16406.0 nM GI50 C9385 Orphanet_217071

Terpenoid-protein target Activity Association

ID Uniport Pref_name Gene name value unit type
TKC032619 P00352 Retinal dehydrogenase 1 ALDH1A1 19953 nM Potency
TKC032619 P10636 Microtubule-associated protein tau MAPT 2239 nM Potency
TKC032619 P11473 Vitamin D3 receptor VDR 31623 nM Potency
TKC032619 Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 TDP1 2311 nM Potency
TKC032619 P08684 Cytochrome P450 3A4 CYP3A4 25119 nM Potency
TKC032619 O75874 Isocitrate dehydrogenase [NADP] cytoplasmic IDH1 16360 nM Potency
TKC032619 P84022 Mothers against decapentaplegic homolog 3 SMAD3 12589 nM Potency
TKC032619 Q03431 Parathyroid hormone/parathyroid hormone-related peptide receptor PTH1R 35481 nM Potency
TKC032619 Q16236 Nuclear factor erythroid 2-related factor 2 NFE2L2 3162 nM Potency
TKC032619 Q99700 Ataxin-2 ATXN2 22387 nM Potency
TKC032619 Q9UBT6 DNA polymerase kappa POLK 1000 nM Potency
TKC032619 O75496 Geminin GMNN 4110 nM Potency
TKC032619 O89049 Thioredoxin reductase 1, cytoplasmic Txnrd1 56234 nM Potency
TKC032619 Q13148 TAR DNA-binding protein 43 TARDBP 14125 nM Potency
TKC032619 P05177 Cytochrome P450 1A2 CYP1A2 10000 nM AC50
TKC032619 P0DTD1 Replicase polyprotein 1ab rep -1 % Inhibition
TKC032619 P83916 Chromobox protein homolog 1 CBX1 79433 nM Potency
TKC032619 Q96KQ7 Histone-lysine N-methyltransferase EHMT2 EHMT2 7943 nM Potency
TKC032619 Q96QE3 ATPase family AAA domain-containing protein 5 ATAD5 25919 nM Potency
TKC032619 Q01453 Peripheral myelin protein 22 PMP22 37933 nM Potency
TKC032619 O00255 Menin MEN1 39811 nM Potency
TKC032619 P02791 Ferritin light chain FTL 50119 nM Potency
TKC032619 P25779 Cruzipain 25119 nM Potency
TKC032619 P49798 Regulator of G-protein signaling 4 RGS4 37686 nM Potency
TKC032619 P11021 Endoplasmic reticulum chaperone BiP HSPA5 14689 nM Potency
TKC032619 P51450 Nuclear receptor ROR-gamma Rorc 3981 nM Potency
TKC032619 P02545 Prelamin-A/C LMNA 5012 nM Potency
TKC032619 P15917 Lethal factor lef 6310 nM Potency
TKC032619 O15118 NPC intracellular cholesterol transporter 1 NPC1 92000 nM Potency
TKC032619 P51151 Ras-related protein Rab-9A RAB9A 58048 nM Potency
TKC032619 P42345 Serine/threonine-protein kinase mTOR MTOR 2931 nM Potency
TKC032619 P04637 Cellular tumor antigen p53 TP53 15849 nM Potency
TKC032619 Q548M1 60 kDa chaperonin groL 70 % Inhibition
TKC032619 P0A6C1 Endonuclease 4 nfo 12589 nM Potency
TKC032619 P42226 Signal transducer and activator of transcription 6 STAT6 7943 nM Potency
TKC032619 Q99549 M-phase phosphoprotein 8 MPHOSPH8 891 nM Potency

Protein target-disease Activity Association

Uniport ID Uniport Name ICD-11
P10636 TAU_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P10636 TAU_HUMAN Alzheimer disease [ICD-11: 8A20]
P10636 TAU_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P10636 TAU_HUMAN Choreiform disorder [ICD-11: 8A01]
P10636 TAU_HUMAN Parkinsonism [ICD-11: 8A00]
P10636 TAU_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P10636 TAU_HUMAN Neurodegenerative disorder [ICD-11: 8A20-8A23]
P11473 VDR_HUMAN Chronic kidney disease [ICD-11: GB61]
P11473 VDR_HUMAN Hair/hair growth developmental defect [ICD-11: LC30]
P11473 VDR_HUMAN Hyper-parathyroidism [ICD-11: 5A51]
P11473 VDR_HUMAN Hypo-parathyroidism [ICD-11: 5A50]
P11473 VDR_HUMAN Mineral deficiency [ICD-11: 5B5K]
P11473 VDR_HUMAN Psoriasis [ICD-11: EA90]
P11473 VDR_HUMAN Vitamin deficiency [ICD-11: 5B55-5B5F]
P11473 VDR_HUMAN Low bone mass disorder [ICD-11: FB83]
P11473 VDR_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P11473 VDR_HUMAN Prostate cancer [ICD-11: 2C82]
P11473 VDR_HUMAN Prostate disease [ICD-11: GA91]
P11473 VDR_HUMAN Abnormal micturition [ICD-11: MF50]
P11473 VDR_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P11473 VDR_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P11473 VDR_HUMAN Acne vulgaris [ICD-11: ED80]
P08684 CP3A4_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P08684 CP3A4_HUMAN Atopic eczema [ICD-11: EA80]
P08684 CP3A4_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
O75874 IDHC_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
O75874 IDHC_HUMAN Liver cancer [ICD-11: 2C12]
O75874 IDHC_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
O75874 IDHC_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O75874 IDHC_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
O75874 IDHC_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P84022 SMAD3_HUMAN Herpes simplex infection [ICD-11: 1F00]
P84022 SMAD3_HUMAN Kidney fibrosis [ICD-11: GC01]
Q03431 PTH1R_HUMAN Low bone mass disorder [ICD-11: FB83]
Q03431 PTH1R_HUMAN Hypo-parathyroidism [ICD-11: 5A50]
Q16236 NF2L2_HUMAN Ataxic disorder [ICD-11: 8A03]
Q16236 NF2L2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q16236 NF2L2_HUMAN Glaucoma [ICD-11: 9C61]
Q16236 NF2L2_HUMAN Lung cancer [ICD-11: 2C25]
Q16236 NF2L2_HUMAN Macular degeneration [ICD-11: 9B75]
Q16236 NF2L2_HUMAN Melanoma [ICD-11: 2C30]
Q16236 NF2L2_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
Q16236 NF2L2_HUMAN Pulmonary hypertension [ICD-11: BB01]
Q16236 NF2L2_HUMAN Subarachnoid haemorrhage [ICD-11: 8B01]
Q16236 NF2L2_HUMAN Urinary system clinical sympton [ICD-11: MF8Y]
Q16236 NF2L2_HUMAN Non-alcoholic fatty liver disease [ICD-11: DB92]
Q16236 NF2L2_HUMAN Alpha-1-antitrypsin deficiency [ICD-11: 5C5A]
Q16236 NF2L2_HUMAN Motor neuron disease [ICD-11: 8B60]
Q16236 NF2L2_HUMAN Multiple sclerosis [ICD-11: 8A40]
Q13148 TADBP_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
Q13148 TADBP_HUMAN Alzheimer disease [ICD-11: 8A20]
Q96KQ7 EHMT2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q96KQ7 EHMT2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
Q96KQ7 EHMT2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P25779 CYSP_TRYCR Parasitic worm infestation [ICD-11: 1F90]
P25779 CYSP_TRYCR Malaria [ICD-11: 1F40-1F45]
P11021 BIP_HUMAN Melanoma [ICD-11: 2C30]
P11021 BIP_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P15917 LEF_BACAN Sepsis [ICD-11: 1G40-1G41]
P15917 LEF_BACAN Corneal disease [ICD-11: 9A76-9A78]
P51151 RAB9A_HUMAN Fungal infection [ICD-11: 1F29-1F2F]
P42345 MTOR_HUMAN Arteries/arterioles disorder [ICD-11: BD52]
P42345 MTOR_HUMAN Chronic myelomonocytic leukaemia [ICD-11: 2A40]
P42345 MTOR_HUMAN Hydrocephalus [ICD-11: 8D64]
P42345 MTOR_HUMAN Multiple myeloma [ICD-11: 2A83]
P42345 MTOR_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P42345 MTOR_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42345 MTOR_HUMAN Transplant rejection [ICD-11: NE84]
P42345 MTOR_HUMAN Sarcoma [ICD-11: 2A60-2C35]
P42345 MTOR_HUMAN Bladder cancer [ICD-11: 2C94]
P42345 MTOR_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42345 MTOR_HUMAN Endometrial cancer [ICD-11: 2C76]
P42345 MTOR_HUMAN Head and neck cancer [ICD-11: 2D42]
P42345 MTOR_HUMAN Liver cancer [ICD-11: 2C12]
P42345 MTOR_HUMAN Lung cancer [ICD-11: 2C25]
P42345 MTOR_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42345 MTOR_HUMAN Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y]
P42345 MTOR_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42345 MTOR_HUMAN Pain [ICD-11: MG30-MG3Z]
P42345 MTOR_HUMAN Pancreatic cancer [ICD-11: 2C10]
P42345 MTOR_HUMAN Prostate cancer [ICD-11: 2C82]
P42345 MTOR_HUMAN Pulmonary hypertension [ICD-11: BB01]
P42345 MTOR_HUMAN Lymphangioleiomyomatosis [ICD-11: CB07]
P42345 MTOR_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P42345 MTOR_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P42345 MTOR_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P42345 MTOR_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P42345 MTOR_HUMAN Ulcerative colitis [ICD-11: DD71]
P04637 P53_HUMAN Arterial occlusive disease [ICD-11: BD40]
P04637 P53_HUMAN Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E]
P04637 P53_HUMAN Metastatic liver/bile duct neoplasm [ICD-11: 2D80]
P04637 P53_HUMAN Transplant rejection [ICD-11: NE84]
P04637 P53_HUMAN Ovarian dysfunction [ICD-11: 5A80]
P04637 P53_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P04637 P53_HUMAN Bladder cancer [ICD-11: 2C94]
P04637 P53_HUMAN Brain cancer [ICD-11: 2A00]
P04637 P53_HUMAN Colorectal cancer [ICD-11: 2B91]
P04637 P53_HUMAN Esophageal cancer [ICD-11: 2B70]
P04637 P53_HUMAN Head and neck cancer [ICD-11: 2D42]
P04637 P53_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P04637 P53_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P04637 P53_HUMAN Ovarian cancer [ICD-11: 2C73]
P04637 P53_HUMAN Pancreatic cancer [ICD-11: 2C10]
P04637 P53_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P04637 P53_HUMAN Stomach cancer [ICD-11: 2B72]
P04637 P53_HUMAN Cervical cancer [ICD-11: 2C77]
P04637 P53_HUMAN Endometrial cancer [ICD-11: 2C76]
P04637 P53_HUMAN Fallopian tube cancer [ICD-11: 2C74]
P04637 P53_HUMAN Liposarcoma [ICD-11: 2B59]
P04637 P53_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P04637 P53_HUMAN Peritoneal cancer [ICD-11: 2C51]
P04637 P53_HUMAN Toxicity [ICD-11: N.A.]
P04637 P53_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P04637 P53_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P04637 P53_HUMAN Kidney failure [ICD-11: GB60-GB6Z]
P04637 P53_HUMAN Hearing disorder [ICD-11: AB50-AB57]